These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

603 related items for PubMed ID: 20128443

  • 1. QuantiFERON-TB Gold In-Tube test (QFT-GIT) for the screening of latent tuberculosis in recent immigrants to Italy.
    Saracino A, Scotto G, Fornabaio C, Martinelli D, Faleo G, Cibelli D, Tartaglia A, Di Tullio R, Fazio V, Prato R, Monno L, Angarano G.
    New Microbiol; 2009 Oct; 32(4):369-76. PubMed ID: 20128443
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection in hemodialysis patients.
    Seyhan EC, Sökücü S, Altin S, Günlüoğlu G, Trablus S, Yilmaz D, Koksalan OK, Issever H.
    Transpl Infect Dis; 2010 Apr; 12(2):98-105. PubMed ID: 19903322
    [Abstract] [Full Text] [Related]

  • 3. QuantiFERON-TB Gold In-Tube for the detection of Mycobacterium tuberculosis infection in children with household tuberculosis contact.
    Kasambira TS, Shah M, Adrian PV, Holshouser M, Madhi SA, Chaisson RE, Martinson NA, Dorman SE.
    Int J Tuberc Lung Dis; 2011 May; 15(5):628-34. PubMed ID: 21756513
    [Abstract] [Full Text] [Related]

  • 4. Mycobacterium Tuberculosis Infection, Immigration Status, and Diagnostic Discordance: A Comparison of Tuberculin Skin Test and QuantiFERON-TB Gold In-Tube Test Among Immigrants to the U.S.
    Wilson FA, Miller TL, Stimpson JP.
    Public Health Rep; 2016 May; 131(2):303-10. PubMed ID: 26957665
    [Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness of the NICE guidelines for screening for latent tuberculosis infection: the QuantiFERON-TB Gold IGRA alone is more cost-effective for immigrants from high burden countries.
    Hardy AB, Varma R, Collyns T, Moffitt SJ, Mullarkey C, Watson JP.
    Thorax; 2010 Feb; 65(2):178-80. PubMed ID: 19996345
    [Abstract] [Full Text] [Related]

  • 6. Serial interferon-gamma release assays after rifampicin prophylaxis in a tuberculosis outbreak.
    Lee SH, Lew WJ, Kim HJ, Lee HK, Lee YM, Cho CH, Lee EJ, Lee DY, Ryu SW, Oh SY, Kim SO, Shim TS.
    Respir Med; 2010 Mar; 104(3):448-53. PubMed ID: 19879123
    [Abstract] [Full Text] [Related]

  • 7. QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases.
    Bartalesi F, Vicidomini S, Goletti D, Fiorelli C, Fiori G, Melchiorre D, Tortoli E, Mantella A, Benucci M, Girardi E, Cerinic MM, Bartoloni A.
    Eur Respir J; 2009 Mar; 33(3):586-93. PubMed ID: 19047313
    [Abstract] [Full Text] [Related]

  • 8. Cost-effectiveness of QuantiFERON-TB test vs. tuberculin skin test in the diagnosis of latent tuberculosis infection.
    Deuffic-Burban S, Atsou K, Viget N, Melliez H, Bouvet E, Yazdanpanah Y.
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):471-81. PubMed ID: 20202306
    [Abstract] [Full Text] [Related]

  • 9. Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts.
    Arend SM, Thijsen SF, Leyten EM, Bouwman JJ, Franken WP, Koster BF, Cobelens FG, van Houte AJ, Bossink AW.
    Am J Respir Crit Care Med; 2007 Mar 15; 175(6):618-27. PubMed ID: 17170386
    [Abstract] [Full Text] [Related]

  • 10. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population.
    Ponce de Leon D, Acevedo-Vasquez E, Alvizuri S, Gutierrez C, Cucho M, Alfaro J, Perich R, Sanchez-Torres A, Pastor C, Sanchez-Schwartz C, Medina M, Gamboa R, Ugarte M.
    J Rheumatol; 2008 May 15; 35(5):776-81. PubMed ID: 18398944
    [Abstract] [Full Text] [Related]

  • 11. Comparison of QuantiFERON-TB Gold with tuberculin skin test for detection of latent tuberculosis infection before kidney transplantation.
    Kim JS, Cho JH, Park GY, Kang YJ, Kwon O, Choi JY, Park SH, Kim YL, Kim HK, Huh S, Kim CD.
    Transplant Proc; 2013 Oct 15; 45(8):2899-902. PubMed ID: 24157000
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of QuantiFERON-TB Gold In-Tube in human immunodeficiency virus infection and in patient candidates for anti-tumour necrosis factor-alpha treatment.
    Sauzullo I, Mengoni F, Scrivo R, Valesini G, Potenza C, Skroza N, Marocco R, Lichtner M, Vullo V, Mastroianni CM.
    Int J Tuberc Lung Dis; 2010 Jul 15; 14(7):834-40. PubMed ID: 20550765
    [Abstract] [Full Text] [Related]

  • 13. [Tuberculosis screening program for undocumented immigrant teenagers using the QuantiFERON(®)-TB Gold In-Tube test].
    Salinas C, Ballaz A, Díez R, Aguirre U, Antón A, Altube L.
    Med Clin (Barc); 2015 Jul 06; 145(1):7-13. PubMed ID: 24747025
    [Abstract] [Full Text] [Related]

  • 14. School based screening for tuberculosis infection in Norway: comparison of positive tuberculin skin test with interferon-gamma release assay.
    Winje BA, Oftung F, Korsvold GE, Mannsåker T, Ly IN, Harstad I, Dyrhol-Riise AM, Heldal E.
    BMC Infect Dis; 2008 Oct 17; 8():140. PubMed ID: 18928541
    [Abstract] [Full Text] [Related]

  • 15. QuantiFERON-TB Gold test in the identification of latent tuberculosis infection in immigrants.
    Carvalho AC, Pezzoli MC, El-Hamad I, Arce P, Bigoni S, Scarcella C, Indelicato AM, Scolari C, Carosi G, Matteelli A.
    J Infect; 2007 Aug 17; 55(2):164-8. PubMed ID: 17428542
    [Abstract] [Full Text] [Related]

  • 16. Detection of Mycobacterium tuberculosis infection in United States Navy recruits using the tuberculin skin test or whole-blood interferon-gamma release assays.
    Mazurek GH, Zajdowicz MJ, Hankinson AL, Costigan DJ, Toney SR, Rothel JS, Daniels LJ, Pascual FB, Shang N, Keep LW, LoBue PA.
    Clin Infect Dis; 2007 Oct 01; 45(7):826-36. PubMed ID: 17806046
    [Abstract] [Full Text] [Related]

  • 17. Tuberculin skin test and QuantiFERON-Gold In Tube assay for diagnosis of latent TB infection among household contacts of pulmonary TB patients in high TB burden setting.
    Chandrasekaran P, Mave V, Thiruvengadam K, Gupte N, Shivakumar SVBY, Hanna LE, Kulkarni V, Kadam D, Dhanasekaran K, Paradkar M, Thomas B, Kohli R, Dolla C, Bharadwaj R, Sivaramakrishnan GN, Pradhan N, Gupte A, Murali L, Valvi C, Swaminathan S, Gupta A, CTRIUMPH Study Team.
    PLoS One; 2018 Oct 01; 13(8):e0199360. PubMed ID: 30067752
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.